Insulin-like Growth Factor-1 Receptor in Tobacco Smoking-Associated Lung Cancer Development
Schematic representation of the IGF/IGF-1R axis: (1) Insulin-like growth factor (IGF-1/2) binds to its receptor, insulin-like growth factor receptor 1 (IGF-1R), triggering a cascade of events that ultimately lead to the activation of the insulin receptor substrate (IRS). Once activated, IRS initiates the PI3K-AKT signaling pathway, which plays a crucial role in promoting cell survival. This is achieved through a reduction in apoptosis, a process of programmed cell death, and an increase in protein synthesis, which aids in cellular growth and maintenance. Overall, the activation of IRS and the subsequent PI3K-AKT signaling pathway are essential for maintaining healthy cellular functions. (2) The SHC protein acts as a signal transducer, triggering the activation of the Ras/MEK/ERK and JNK/MAPK pathways. These pathways, in turn, activate specific transcription factors that regulate the expression of target genes. By orchestrating this complex signaling cascade, the SHC protein plays a crucial role in coordinating cellular responses to diverse extracellular stimuli. This process is essential for maintaining cellular homeostasis and adapting to changing environmental conditions. (3) In addition to the activation of ligand-dependent signaling pathways, insulin-like growth factor-binding proteins (IGFBPs) 1–6 can also trigger ligand-independent signaling pathways. This means that IGFBPs can influence cellular processes even when not bound to IGFs. IGF-1R: Insulin-like growth factor receptor 1; PI3K: Phosphatidylinositol-3-kinase; AKT: Serine/threonine kinase, named protein kinase B (PKB); mTOR: Mammalian target of rapamycin; Bad: Bcl-2-associated death promoter; Bcl2: B-cell lymphoma 2; Shc: Adaptor protein; Ras: GTPase protein; JNK: c-Jun N-terminal kinase; MEK: Mitogen-activated protein kinase kinase; ERK: Extracellular regulated kinase; MAPK: Mitogen-activated protein kinase; ELK: ETS domain-containing protein